Addex Therapeutics Ltd (ADXN) - Forvard P/S multiplikatori
Shveytsariyaning sog'liqni saqlash giganti Addex Therapeutics (ADXN) siyosiy xavflarni bartaraf etuvchi dori vositalarining gumanitar maqomi bilan himoyalangan. Dorilarni yetkazib berish paytidagi qat'iy iqlim nazorati logistika xarajatlarini oshirsa-da, sinovlar xavfsizligini ta'minlaydi. Daromadlar Parkinson kasalligini davolash uchun neyroterapiyani tijoratlashtirishga asoslangan. Ushbu grafikdagi forward price-to-sales koeffitsiyenti ko'rsatkich qiymati 56.40 ekanligini ko'rsatmoqda.
Addex (ADXN) moliyaviy va bozor koʻrsatkichlari kesimi
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- emitentning balans qiymati statistikasi:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Addex Therapeutics|ADXN - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Addex Therapeutics|ADXN - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Addex|ADXN - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Addex Therapeutics|Tezkor likvidlik koeffitsiyenti addextherapeutics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ADXN - Sof moliyaviy natija|Prognoz qilingan kelajakdagi foyda Addex Therapeutics|ADXN - Narx-foyda koeffitsiyenti|Kelajakdagi narxning foydaga nisbati Addex Therapeutics, Ltd.|ADXN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|EV/EBITDA multiplikatori Addex|ADXN - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Addex Therapeutics|ADXN - So'nggi 12 oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi addextherapeutics.com|ADXN - Bu yil bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Addex Therapeutics
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning dastlabki tahlili:Addex Therapeutics Ltd (ADXN)
Noyob MKN patentlariga egaligi va keng ko'lamli tadqiqotlar hamda ishlanmalar (R&D) orqali yangi ishtirokchilar uchun kirish to'siqlarini saqlab qolgan holda, Addex Therapeutics (ADXN) qat'iy FDA nazorati ostida faoliyat yuritadi. Forward P/S ko'rsatkichi kutilayotgan muvaffaqiyat uchun to'langan premiumni aniqlash uchun kompaniyaning joriy bahosini prognoz qilingan daromadlar bilan solishtiradi. Ushbu forward P/S ko'rsatkichini tahlil qilish orqali investor biznesni sotib olish qiymatiga oid bozor kutuvlari asosli yoki yo'qligini baholaydi.
Addex Therapeutics raqobatchilari
Forvard P/S multiplikatori BIIB (Biogen)|Sotuvga nisbatan forvard narx NBIX|Regencell - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Axsome Corp|ACADIA Pharmaceuticals (ACAD) - Narxning prognoz qilingan daromadga nisbati|xenon-pharma.com - Sotuvga nisbatan forvard narx|VKTX (Viking Therapeutics, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Supernus Pharmaceuticals, Inc.|Narxning prognoz qilingan daromadga nisbati Catalyst Pharmaceuticals Inc (CPRX)|DNLI: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|biohavenpharma.com (BHVN) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|AMLX: Forvard narx/daromad multiplikatori|TRVI - Forvard P/S multiplikatori|PRAX (Praxis Medicines) - Forvard narx/daromad multiplikatori|AVXL: Narxning kutilayotgan daromadga nisbati|CBLL (CeriBell, Inc.) - Forvard P/S multiplikatori|Prothena Corporation (PRTA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori ALEC|Forvard narx/daromad multiplikatori Annexon Biosciences ANNX|Narxning prognoz qilingan daromadga nisbati Omeros OMER|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurogene Therapeutics (NGNE)|AC Immune - Forvard P/S multiplikatori|VYGR - Forvard P/S multiplikatori|NMRA: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati SCLX|Forvard narx/daromad multiplikatori TVGN|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ACOG (Alpha Cognition Corp)|Narxning prognoz qilingan daromadga nisbati Cognition Therapeutics (CGTX)|inhibikase.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Cassava Sciences SAVA|ASRT: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Coya - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vistagen Therapeutics|OVID (ovidrx.com) - Forvard narx/daromad multiplikatori|acumenpharm.com (ABOS) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati CervoMed|ATHE: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Clene Inc. (CLNN)|PEPG - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori JUNS (Jupiter Neurosciences Inc)|Forvard P/S multiplikatori relmada.com RLMD|Annovis Bio - Forvard P/S multiplikatori|GRCE (Grace Therapeutics, Inc.) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|AIFF: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati KLTO|NRSN (NeuroSense Therapeutics Ltd) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati revivapharma.com RVPH|Forvard narx/daromad multiplikatori MTVA (MetaVia Inc)|NeurAxis Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Helius Medical Technologies - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PASG|NEUP: Forvard narx/daromad multiplikatori|minervaneurosciences.com - Narxning kutilayotgan daromadga nisbati|ATHA: Forvard P/S multiplikatori|Alzamend Neuro - Sotuvga nisbatan forvard narx|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Protagenic PTIX|Narxning prognoz qilingan daromadga nisbati Pasithea Therapeutics (KTTA)|CRGT (cortigent.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ATXI (Avenue Therapeutics, Inc.)|Forvard P/S multiplikatori Brainstorm Cell Therapeutics Inc. BCLI|CARA - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati CHRO|ELYM: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Intra-Cellular Therapies, Inc. (ITCI)|Forvard narx/daromad multiplikatori LBPH|Forvard P/S multiplikatori Marinus Pharmaceuticals Inc|Forvard narx/daromad multiplikatori NKGN (NKGen)|Narxning kutilayotgan daromadga nisbati NRBO|Forvard P/S multiplikatori SAGE (Sage Therapeutics, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati synaptogen.com (SNPX)|Trevena - Forvard P/S multiplikatori|Vigil Neuroscience (VIGL) - Forvard narx/daromad multiplikatori|Anew Medical (WENA) - Narxning prognoz qilingan daromadga nisbati|CERE - Kapitalizatsiyaning kutilayotgan sotuvga nisbati
